Depend® Brand Taps Emmitt Smith for Annual Stand Strong for Men's Health Campaign Benefitting the Prostate Cancer Foundation
Depend® brand has launched its fifth annual Stand Strong for Men's Health™ campaign, partnering with football legend Emmitt Smith to raise awareness for prostate cancer. The initiative aims to demystify taboos surrounding prostate cancer screenings and side effects, encouraging men to prioritize their health. Depend® has donated over $1 million to the Prostate Cancer Foundation (PCF) in the past five years and plans to donate up to $300,000 from select product sales between September and November 2024.
The campaign highlights the importance of early detection, as prostate cancer has a 99.9% survival rate if caught early. It also promotes new screening methods, such as the PSA blood test, and advances in treatment like the PSMA-PET scan technology. Emmitt Smith, whose father was diagnosed with prostate cancer, is using his platform to normalize conversations around men's health and motivate more men to get checked.
Il marchio Depend® ha lanciato la sua quinta campagna annuale Stand Strong for Men's Health™, in collaborazione con la leggenda del football Emmitt Smith, per sensibilizzare sul cancro alla prostata. L'iniziativa si propone di demistificare i tabù riguardanti gli screening per il cancro alla prostata e i relativi effetti collaterali, incoraggiando gli uomini a dare priorità alla propria salute. Negli ultimi cinque anni, Depend® ha donato oltre 1 milione di dollari alla Prostate Cancer Foundation (PCF) e prevede di donare fino a 300.000 dollari dalle vendite di specifici prodotti tra settembre e novembre 2024.
La campagna sottolinea l'importanza della diagnosi precoce, poiché il cancro alla prostata ha un tasso di sopravvivenza del 99,9% se individuato precocemente. Promuove anche nuovi metodi di screening, come il test del sangue PSA, e avanzamenti nel trattamento come la tecnologia della scansione PSMA-PET. Emmitt Smith, il cui padre è stato diagnosticato con cancro alla prostata, sta utilizzando la sua piattaforma per normalizzare le conversazioni sulla salute maschile e motivare più uomini a farsi controllare.
La marca Depend® ha lanzado su quinta campaña anual Stand Strong for Men's Health™, asociándose con la leyenda del fútbol Emmitt Smith para crear conciencia sobre el cáncer de próstata. La iniciativa tiene como objetivo desmitificar los tabúes en torno a las pruebas de cáncer de próstata y sus efectos secundarios, alentando a los hombres a priorizar su salud. Depend® ha a la Prostate Cancer Foundation (PCF) en los últimos cinco años y planea donar hasta 300,000 dólares de las ventas de ciertos productos entre septiembre y noviembre de 2024.
La campaña destaca la importancia de la detección temprana, ya que el cáncer de próstata tiene una tasa de supervivencia del 99.9% si se detecta a tiempo. También promueve nuevos métodos de detección, como el análisis de sangre PSA, y avances en tratamientos como la tecnología de escaneo PSMA-PET. Emmitt Smith, cuyo padre fue diagnosticado con cáncer de próstata, está utilizando su plataforma para normalizar las conversaciones sobre la salud masculina y motivar a más hombres a hacerse chequeos.
Depend® 브랜드는 축구 전설 Emmitt Smith와 파트너십을 맺고 전립선암에 대한 인식을 높이기 위해 다섯 번째 연례 Stand Strong for Men's Health™ 캠페인을 출범했습니다. 이 이니셔티브는 전립선암 검진과 그 부작용에 대한 금기를 없애고 남성들이 자신의 건강을 우선시하도록 격려하는 것을 목표로 합니다. Depend®는 지난 5년간 100만 달러 이상을 전립선암 재단(PCF)에 기부했으며, 2024년 9월부터 11월 사이에 선택된 제품 판매로부터 30만 달러까지 기부할 계획입니다.
이 캠페인은 전립선암이 조기에 발견될 경우 99.9%의 생존율이 있다는 점에서 조기 발견의 중요성을 강조합니다. 또한 PSA 혈액 검사와 같은 새로운 검사 방법과 PSMA-PET 스캔 기술과 같은 치료의 발전을 홍보합니다. 전립선암 진단을 받은 아버지를 둔 Emmitt Smith는 남성 건강에 대한 대화를 정상화하고 더 많은 남성들에게 검사를 받도록 독려하기 위해 자신의 플랫폼을 활용하고 있습니다.
La marque Depend® a lancé sa cinquième campagne annuelle Stand Strong for Men's Health™, en s'associant à la légende du football Emmitt Smith pour sensibiliser au cancer de la prostate. L'initiative vise à démystifier les tabous entourant les dépistages du cancer de la prostate et ses effets secondaires, en encourageant les hommes à donner la priorité à leur santé. Depend® a fait un don de plus d'un million de dollars à la Prostate Cancer Foundation (PCF) au cours des cinq dernières années et prévoit de donner jusqu'à 300 000 dollars à partir des ventes de certains produits entre septembre et novembre 2024.
La campagne souligne l'importance du dépistage précoce, car le cancer de la prostate présente un taux de survie de 99,9% s'il est détecté tôt. Elle promeut également de nouvelles méthodes de dépistage, comme le test sanguin PSA, ainsi que des avancées dans le traitement, telles que la technologie d'imagerie PSMA-PET. Emmitt Smith, dont le père a été diagnostiqué d'un cancer de la prostate, utilise sa plateforme pour normaliser les conversations autour de la santé masculine et motiver davantage d'hommes à se faire contrôler.
Die Marke Depend® hat ihre fünfte jährliche Stand Strong for Men's Health™-Kampagne gestartet und arbeitet mit Fußballlegende Emmitt Smith zusammen, um das Bewusstsein für Prostatakrebs zu schärfen. Die Initiative hat das Ziel, Tabus rund um Prostatakrebsuntersuchungen und Nebenwirkungen zu entmystifizieren und Männer zu ermutigen, ihre Gesundheit zu priorisieren. Depend® hat in den letzten fünf Jahren über 1 Million Dollar an die Prostate Cancer Foundation (PCF) gespendet und plant, zwischen September und November 2024 bis zu 300.000 Dollar aus dem Verkauf ausgewählter Produkte zu spenden.
Die Kampagne hebt die Bedeutung der Früherkennung hervor, da die Überlebensrate bei Prostatakrebs bei frühzeitiger Erkennung 99,9% beträgt. Außerdem werden neue Screeningsmethoden wie der PSA-Bluttest und Fortschritte in der Behandlung, wie die PSMA-PET-Scan-Technologie, gefördert. Emmitt Smith, dessen Vater mit Prostatakrebs diagnostiziert wurde, nutzt seine Plattform, um Gespräche über die Gesundheit von Männern zu normalisieren und mehr Männer zu motivieren, sich untersuchen zu lassen.
- Depend® has donated over $1 million to the Prostate Cancer Foundation in the last five years
- The company plans to donate up to $300,000 from select product sales between September and November 2024
- Partnership with high-profile athlete Emmitt Smith to raise awareness for the campaign
- None.
Insights
The partnership between Depend® and Emmitt Smith for the Stand Strong for Men's Health campaign is a strategic move to raise awareness about prostate cancer and associated bladder issues. While the campaign's noble cause is commendable, its direct impact on Depend's parent company, Kimberly-Clark (NYSE: KMB), is likely to be minimal in the short term.
The donation of
Investors should view this as a positive brand-building exercise rather than a significant financial driver. The campaign's success in destigmatizing prostate health issues could lead to increased product adoption, but any financial impact would likely be gradual and difficult to quantify directly.
The Depend® campaign's focus on prostate cancer awareness aligns with critical medical trends. The mention of new screening methods, particularly the PSA blood test, highlights the importance of early detection in improving survival rates. This emphasis on preventative care could indirectly benefit the healthcare sector, potentially increasing demand for diagnostic services and treatments.
The campaign's support for the Prostate Cancer Foundation's research, particularly advancements like the PSMA-PET scan, is noteworthy. This technology's ability to detect smaller, earlier-stage cancers could revolutionize prostate cancer management, potentially leading to earlier interventions and improved outcomes. For investors, this signals potential growth in the medical imaging and precision oncology sectors.
While the campaign itself may not directly impact stock prices, the broader trend towards personalized medicine and advanced diagnostics in cancer care represents a significant opportunity for companies operating in these spaces. Investors should monitor developments in PSMA-based technologies and companies at the forefront of these advancements.
Depend® has donated more than
This Prostate Cancer Awareness Month, Depend® is also teaming up with Emmitt Smith, a legendary former football star and record-setting rusher whose exceptional career established him as one of football's greatest players. Beyond his sports career, Smith has been involved in various philanthropic efforts and he understands first-hand the realities of prostate cancer – his late father was diagnosed with the disease. This fall, he's using his platform to normalize conversations around men's health and motivate more men to get checked and champion those who take control of their health.
"It's so easy to avoid medical checkups and preventative care, but confronting these issues head-on is the ultimate display of strength," said Emmitt Smith. "I've experienced the impact that this disease has on families, which is why I'm taking part in the Depend Stand Strong for Men's Health campaign, to encourage others to prioritize their health and get screened."
New preventative screening can start with a simple blood test to detect the level of prostate-specific antigen (PSA), a protein released into the bloodstream, which can catch the disease at an early stage when treatment may be more effective.2
Since launching its Stand Strong for Men's Health™ campaign in 2020, Depend has donated more than
For men diagnosed with prostate cancer, research funded by PCF has led to breakthroughs in evaluation and treatment, such as the prostate-specific membrane antigen (PSMA)-PET scan. This technology allows doctors to see and track otherwise hard-to-find prostate cancer, potentially earlier and in much smaller amounts compared with imaging that is currently used. PSMA-based technology can also be used as a treatment for certain types of advanced prostate cancer to precisely deliver tiny doses of radiation to prostate cancer cells.
More info about the Stand Strong for Men's Health™ initiative can be found at Depend.com/Stand-Strong. For more on the Prostate Cancer Foundation and how Depend® is helping to accelerate its research mission, please visit: pcf.org/depend.
About the Depend® Brand
Launched in 1984 by Kimberly-Clark Corporation, the Depend® brand is the market leader in the adult incontinence category in North America. Over the years, the Depend® brand has evolved with its consumers to provide the exceptional protection and lend them the confidence they need to lead normal, active lives. For more information or to request a product sample, visit www.Depend.com.
About Kimberly-Clark
Kimberly-Clark (NYSE: KMB) and its trusted brands are an indispensable part of life for people in more than 175 countries. Fueled by ingenuity, creativity, and an understanding of people's most essential needs, we create products that help individuals experience more of what's important to them. Our portfolio of brands, including Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, GoodNites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll, hold No. 1 or No. 2 share positions in approximately 70 countries. We use sustainable practices that support a healthy planet, build strong communities, and ensure our business thrives for decades to come. We are proud to be recognized as one of the World's Most Ethical Companies(R) by Ethisphere for the sixth year in a row and one of Fortune's Most Innovative Companies in America in 2024. To keep up with the latest news and to learn more about the company's 150-year history of innovation, visit the Kimberly-Clark website.
About the Prostate Cancer Foundation
The Prostate Cancer Foundation (PCF) is the world's leading philanthropic organization dedicated to funding life-saving prostate cancer research. Founded in 1993 by Mike Milken, PCF has been responsible for raising close to one billion dollars in support of cutting-edge research by more than 2,200 research projects at 245 leading cancer centers in 28 countries around the world. Since PCF's inception, and through its efforts, patients around the world are living longer, suffering fewer complications, and enjoying better quality of life. PCF is committed to creating a global public square for prostate cancer, in service to our mission of ending death and suffering from the disease. Learn more at www.pcf.org.
1 According to the Prostate Cancer Foundation
2 According to the Prostate Cancer Foundation
3 Depend® will donate
[KMB-B]
View original content to download multimedia:https://www.prnewswire.com/news-releases/depend-brand-taps-emmitt-smith-for-annual-stand-strong-for-mens-health-campaign-benefitting-the-prostate-cancer-foundation-302253141.html
SOURCE Kimberly-Clark Corporation
FAQ
What is the Stand Strong for Men's Health campaign by Depend (KMB)?
How much has Depend (KMB) donated to the Prostate Cancer Foundation?
What is the survival rate for prostate cancer if detected early?
Who is partnering with Depend (KMB) for the 2024 Stand Strong for Men's Health campaign?
